Manufacturer record
Tulip Formulations Pvt. Ltd: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
1 batch manufactured by Tulip Formulations Pvt. Ltd (Himachal Pradesh) was declared Not of Standard Quality in June 2021. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: 21001, IBUPROFEN AND PARACETAMOL Tablets (IBULIP-P TABLETS) (exp Mar 2024). RDTL Chandigarh (state lab) found it not of standard quality: Assay of Ibuprofen and Paracetamol. Listed in the June 2021 alert.
Records by type
1 record linked to Tulip Formulations Pvt. Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| IBUPROFEN AND PARACETAMOL Tablets (IBULIP-P TABLETS) | Batch 21001Mfg Apr 2021 · Exp Mar 2024 | Assay of Ibuprofen and ParacetamolAssay | RDTL ChandigarhState lab | Jun 2021 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.